Orthopediatrics Corp
KIDS Nasdaq· Surgical & Medical Instruments & Apparatus
Last close · Oct 23, 2026
$24.50
KIRA · Stoqly’s AI analyst, in plain words
- Orthopediatrics Corp had $236M of revenue in fiscal 2025, up 15.4% on the year before. Over five years, revenue changed +27.2% a year on average.
- Its operating margin was −16.6%, up 0.5 pts: of every 100 in sales, about −17 is left after running the business.
- Orthopediatrics Corp lost $39.6M in fiscal 2025.
- Free cash flow was −$16.0M in fiscal 2025, −6.8% of revenue.
- Orthopediatrics Corp owes $45.2M more than it holds in cash.
Market cap
$589M
P/E
—
Revenue
$236M
Net income
−$39.6M
Free cash flow
−$16.0M
Operating margin
−16.6%
Orthopediatrics Corp in 30 seconds · fiscal 2025
Are sales growing?
+15.4%
Yes. Sales grew 15.4% last year.
Does it make a profit?
−16.8%
No. It lost money last year.
Does profit turn into cash?
−6.8%
No. It spent more cash than it brought in.
How healthy are the accounts?
4 / 9
Mixed. It passes 4 of 9 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What Orthopediatrics Corp does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 4, 2026
- Legal name
- ORTHOPEDIATRICS CORP
- CIK
- 0001425450
Orthopediatrics Corp · KIDS
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $98.0M | $122M | $149M | $205M | $236M |
| Revenue growth | 37.9% | 24.7% | 21.6% | 37.6% | 15.4% |
| Net interest income | −$2.2M | −$2.4M | $0.2M | — | — |
| Gross margin | 74.9% | 74.1% | 74.8% | 72.6% | 73.1% |
| Operating margin | −18.4% | −20.8% | −18.0% | −17.1% | −16.6% |
| Net income | −$16.3M | $1.3M | −$21.0M | −$37.8M | −$39.6M |
| Net margin | −16.6% | 1.0% | −14.1% | −18.5% | −16.8% |
| Diluted EPS | −$0.84 | $0.06 | −$0.92 | −$1.64 | −$1.69 |
| Cash | |||||
| Cash from operations | −$13.1M | −$21.8M | −$27.0M | −$27.0M | −$4.9M |
| Capital expenditure | $8.1M | $10.0M | $16.9M | $14.3M | $11.1M |
| Free cash flow | −$21.2M | −$31.8M | −$43.9M | −$41.3M | −$16.0M |
| FCF margin | −21.6% | −26.0% | −29.5% | −20.2% | −6.8% |
| Share count change | 6.7% | 8.7% | 8.2% | 1.8% | 1.7% |
| Debt and strength | |||||
| Cash and short-term investments | $53.5M | $118M | $80.3M | $68.8M | $60.9M |
| Debt incl. finance leases | $1.0M | $0.9M | $11.1M | $77.5M | $106M |
| Shareholders' equity | $225M | $379M | $377M | $355M | $347M |
| Current ratio | 4.5x | 7.3x | 5.4x | 7.0x | 5.6x |
| Interest coverage | −321.9x | −10.5x | — | −13.4x | −6.5x |
| Returns and quality | |||||
| Return on capital | −8.2% | −7.7% | −6.9% | −7.6% | −7.9% |
| Return on equity | −7.1% | 0.4% | −5.6% | −10.3% | −11.3% |
| Return on tangible equity | −16.7% | 0.5% | −9.4% | −19.3% | −23.0% |
| Piotroski F-score | 4 | 4 | 2 | 3 | 4 |
| Altman Z'' | 2.9 | 9.4 | 7.3 | 3.8 | 2.7 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$32.2M
7 insiders
Of sales under plans
0%
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Orthopediatrics Corp · KIDS
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $24.50 a share, the company is worth $589M.
Source: SEC EDGAR XBRL filings (CIK 0001425450). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.